Cagrilintide
Cagrilintide (AM833, NNC0174-0833)
Long-acting synthetic amylin analogue for weight management and type 2 diabetes. Works as a dual amylin and calcitonin receptor agonist (DACRA), mimicking natural amylin hormone to regulate appetite, slow gastric emptying, and promote satiety.
Complete Dosing Guide
Special Considerations
Kidney Problems:
- No dose adjustment typically needed
- Monitor renal function regularly
Liver Problems:
- Limited data available
- Use with caution in hepatic impairment
Elderly:
- No specific dose adjustments required
- Monitor for increased sensitivity to side effects
Children:
- Not studied in pediatric populations
- Not recommended for use under 18 years
Special Considerations
Kidney Problems
- No dose adjustment typically needed
- Monitor renal function regularly
Liver Problems
- Limited data available
- Use with caution in hepatic impairment
Elderly
- No specific dose adjustments required
- Monitor for increased sensitivity to side effects
Children
- Not studied in pediatric populations
- Not recommended for use under 18 years
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.